Isolation of Borrelia miyamotoi and other Borreliae using a modified BSK medium.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 01 2021
Historique:
received: 03 06 2020
accepted: 16 12 2020
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 24 9 2021
Statut: epublish

Résumé

Borrelia spirochetes are the causative agents of Lyme borreliosis (LB) and relapsing fever (RF). Despite the steady rise in infections and the identification of new species causing human illness over the last decade, isolation of borreliae in culture has become increasingly rare. A modified Barbour-Stoenner-Kelly (BSK) media formulation, BSK-R, was developed for isolation of the emerging RF pathogen, Borrelia miyamotoi. BSK-R is a diluted BSK-II derivative supplemented with Lebovitz's L-15, mouse and fetal calf serum. Decreasing the concentration of CMRL 1066 and other components was essential for growth of North American B. miyamotoi. Sixteen B. miyamotoi isolates, originating from Ixodes scapularis ticks, rodent and human blood collected in the eastern and upper midwestern United States, were isolated and propagated to densities > 10

Identifiants

pubmed: 33479281
doi: 10.1038/s41598-021-81252-1
pii: 10.1038/s41598-021-81252-1
pmc: PMC7820315
doi:

Substances chimiques

Culture Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1926

Références

Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I. & Wormser, G. P. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18(3), 484–509. https://doi.org/10.1128/CMR.18.3.484-509.2005 (2005).
doi: 10.1128/CMR.18.3.484-509.2005 pubmed: 16020686 pmcid: 1195970
Cutler, S. J. et al. Diagnosing borreliosis. Vector Borne Zoonotic Dis. 17(1), 2–11. https://doi.org/10.1089/vbz.2016.1962 (2017).
doi: 10.1089/vbz.2016.1962 pubmed: 28055580
Paules, C. I., Marston, H. D., Bloom, M. E. & Fauci, A. S. Tickborne diseases—confronting a growing threat. N Engl J Med. 379, 701–703. https://doi.org/10.1056/NEJMp1807870 (2018).
doi: 10.1056/NEJMp1807870 pubmed: 30044925
Rosenberg, R. et al. Vital signs: trends in reported vectorborne disease cases—United States and territories, 2004–2016. MMWR Morb. Mortal. Wkly. Rep. 67, 496–501. https://doi.org/10.15585/mmwr.mm6717e1 (2018).
doi: 10.15585/mmwr.mm6717e1 pubmed: 29723166 pmcid: 5933869
Fukunaga, M. et al. Genetic and phenotypic analysis of Borrelia miyamotoi sp nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int. J. Syst. Bacteriol. 45(4), 804–810. https://doi.org/10.1099/00207713-45-4-804 (1995).
doi: 10.1099/00207713-45-4-804 pubmed: 7547303
Barbour, A. G. Cultivation of Borrelia: a historical overview. Zentralbl Bakteriol Mikrobiol Hyg. Ser. A. 263(1–2), 11–14. https://doi.org/10.1016/S0176-6724(86)80095-5 (1986).
doi: 10.1016/S0176-6724(86)80095-5
Kelly, R. Cultivation of Borrelia hermsi. Science 173(3995), 443–444. https://doi.org/10.1126/science.173.3995.443 (1971).
doi: 10.1126/science.173.3995.443 pubmed: 5557322
Barbour, A. G., Burgdorfer, W., Hayes, S. F., Peter, O. & Aeschlimann, A. Isolation of a cultivable spirochete from Ixodes ricinus ticks of Switzerland. Curr. Microbiol. 8(2), 123–126. https://doi.org/10.1007/BF01566969 (1983).
doi: 10.1007/BF01566969
Preac-Mursic, V., Wilske, B. & Schierz, G. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg Ser. A. 263(1–2), 112–118. https://doi.org/10.1016/S0176-6724(86)80110-9 (1986).
doi: 10.1016/S0176-6724(86)80110-9
Pollack, R. J., Telford, S. R. 3rd. & Spielman, A. Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31(5), 1251–1255 (1993).
doi: 10.1128/jcm.31.5.1251-1255.1993
Pritt, B. S. et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect. Dis. 16(5), 556–564. https://doi.org/10.1016/S1473-3099(15)00464-8 (2016).
doi: 10.1016/S1473-3099(15)00464-8 pubmed: 26856777 pmcid: 4975683
Platonov, A. E. et al. Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg. Infect. Dis. 17(10), 1816–1823. https://doi.org/10.3201/eid1710.101474 (2011).
doi: 10.3201/eid1710.101474 pubmed: 22000350 pmcid: 3310649
Gugliotta, J. L., Goethert, H. K., Berardi, V. P. & Telford, S. R. 3rd. Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N. Engl. J. Med. 368(3), 240–245. https://doi.org/10.1056/NEJMoa1209039 (2013).
doi: 10.1056/NEJMoa1209039 pubmed: 23323900 pmcid: 4018741
Scoles, G. A., Papero, M., Beati, L. & Fish, D. A relapsing fever group spirochete transmitted by Ixodes scapularis ticks. Vector Borne Zoonotic Dis. 1(1), 21–34. https://doi.org/10.1089/153036601750137624 (2001).
doi: 10.1089/153036601750137624 pubmed: 12653133
Kingry, L. C. et al. Toward a complete North American Borrelia miyamotoi genome. Genome Announc. 5(5), e01557-e1616. https://doi.org/10.1128/genomeA.01557-16 (2017).
doi: 10.1128/genomeA.01557-16 pubmed: 28153903 pmcid: 5289689
Kingry, L. C. et al. Chromosome and large linear plasmid sequences of a Borrelia miyamotoi strain isolated from Ixodes pacificus ticks from California. Genome Announc. 5(37), e00960-e1017. https://doi.org/10.1128/genomeA.00960-17 (2017).
doi: 10.1128/genomeA.00960-17 pubmed: 28912318 pmcid: 5597759
Stoenner, H. G., Dodd, T. & Larsen, C. Antigenic variation of Borrelia hermsii. J. Exp. Med. 156(5), 1297–1311. https://doi.org/10.1084/jem.156.5.1297 (1982).
doi: 10.1084/jem.156.5.1297 pubmed: 7130900
Barbour, A. G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57(4), 521–525 (1984).
pubmed: 6393604 pmcid: 2589996
Leibovitz, A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am. J. Epidemiol. 78(2), 173–180. https://doi.org/10.1093/oxfordjournals.aje.a120336 (1963).
doi: 10.1093/oxfordjournals.aje.a120336
Kurtenbach, K., Sewell, H. S., Ogden, N. H., Randolph, S. E. & Nuttall, P. A. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect. Immun. 66(3), 1248–1251. https://doi.org/10.1128/iai.66.3.1248-1251.1998 (1998).
doi: 10.1128/iai.66.3.1248-1251.1998 pubmed: 9488421 pmcid: 108041
Margos, G. et al. Long-term in vitro cultivation of Borrelia miyamotoi. Ticks Tick Borne Dis. 6(2), 181–184. https://doi.org/10.1016/j.ttbdis.2014.12.001 (2015).
doi: 10.1016/j.ttbdis.2014.12.001 pubmed: 25561082
Koetsveld, J. et al. Development and optimization of an in vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever. Clin. Microbiol. Infect. 23(7), 480–484. https://doi.org/10.1016/j.cmi.2017.01.009 (2017).
doi: 10.1016/j.cmi.2017.01.009 pubmed: 28110053
Marques, A. R. et al. Citrate anticoagulant improves the sensitivity of Borreliella (Borrelia) burgdorferi plasma culture. J. Clin. Microbiol. 55(11), 3297–3299. https://doi.org/10.1128/JCM.01046-17 (2017).
doi: 10.1128/JCM.01046-17 pubmed: 28878005 pmcid: 5654915
Benach, J. L. et al. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 308, 740–742. https://doi.org/10.1056/NEJM198303313081302 (1983).
doi: 10.1056/NEJM198303313081302 pubmed: 6828119
Kingry, L. C. et al. Surveillance for and discovery of Borrelia species in US patients suspected of tickborne illness. Clin. Infect. Dis. 66, 1864–1871. https://doi.org/10.1093/cid/cix1107 (2018).
doi: 10.1093/cid/cix1107 pubmed: 29272385
Wang, G. et al. Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect. Immun. 72(11), 6702–6706. https://doi.org/10.1128/IAI.72.11.6702-6706.2004 (2004).
doi: 10.1128/IAI.72.11.6702-6706.2004 pubmed: 15501807 pmcid: 523011
Dolan, M. C. et al. Vector competence of the blacklegged tick, Ixodes scapularis, for the recently recognized Lyme borreliosis spirochete Candidatus Borrelia mayonii. Ticks Tick Borne Dis. 7(5), 665–669. https://doi.org/10.1016/j.ttbdis.2016.02.012 (2016).
doi: 10.1016/j.ttbdis.2016.02.012 pubmed: 26922324
Lynn, G. E. et al. An immunocompromised mouse model to infect Ixodes scapularis ticks with the relapsing fever spirochete, Borrelia miyamotoi. Tick Borne Dis. 10(2), 352–359. https://doi.org/10.1016/j.ttbdis.2018.11.017 (2019).
doi: 10.1016/j.ttbdis.2018.11.017
Breuner, N. E., Hojgaard, A., Replogle, A. J., Boegler, K. A. & Eisen, L. Transmission of the relapsing fever spirochete, Borrelia miyamotoi, by single transovarially-infected larval Ixodes scapularis ticks. Ticks Tick Borne Dis. 9(6), 1464–1467. https://doi.org/10.1016/j.ttbdis.2018.07.006 (2018).
doi: 10.1016/j.ttbdis.2018.07.006 pubmed: 30007502 pmcid: 6135663
Dolan, M. C. et al. Transmission of the Lyme disease spirochete Borrelia mayonii in relation to duration of attachment by nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol. 54(5), 1360–1364. https://doi.org/10.1093/jme/tjx089 (2017).
doi: 10.1093/jme/tjx089 pubmed: 28874016 pmcid: 5968629
Breuner, N. E. et al. Transmission of Borrelia miyamotoi sensu lato relapsing fever group spirochetes in relation to duration of attachment by Ixodes scapularis nymphs. Ticks Tick Borne Dis. 8(5), 677–681. https://doi.org/10.1016/j.ttbdis.2017.03.008 (2017).
doi: 10.1016/j.ttbdis.2017.03.008 pubmed: 28501504 pmcid: 5665651
Dolan, M. C. et al. Duration of Borrelia mayonii infectivity in an experimental mouse model for feeding Ixodes scapularis larvae. Ticks Tick Borne Dis. 8(1), 196–200. https://doi.org/10.1016/j.ttbdis.2016.11.002 (2017).
doi: 10.1016/j.ttbdis.2016.11.002 pubmed: 27838290
Eisen, L. et al. Comparison of vector efficiency of Ixodes scapularis (Acari: Ixodidae) from the northeast and upper midwest of the United States for the Lyme disease spirochete Borrelia mayonii. J. Med. Entomol. 54(1), 239–242. https://doi.org/10.1093/jme/tjw160 (2017).
doi: 10.1093/jme/tjw160 pubmed: 28082653
Campbell, S. B. et al. Evaluating the risk of tick-borne relapsing fever among occupational cavers—Austin, TX, 2017. Zoonoses Public Health. 66(6), 579–586. https://doi.org/10.1111/zph.12588 (2019).
doi: 10.1111/zph.12588 pubmed: 31152496 pmcid: 7042895
Johnson, T. L. et al. Isolation of the Lyme disease spirochete Borrelia mayonii from naturally infected rodents in Minnesota. J. Med. Entomol. 54(4), 1088–1092. https://doi.org/10.1093/jme/tjx062 (2017).
doi: 10.1093/jme/tjx062 pubmed: 28444198 pmcid: 5664935
Kingry, L. C. et al. Whole genome sequence and comparative genomics of the novel Lyme Borreliosis causing pathogen, Borrelia mayonii. PLoS ONE 11(12), e0168994. https://doi.org/10.1371/journal.pone.0168994 (2016).
doi: 10.1371/journal.pone.0168994 pubmed: 28030649 pmcid: 5193363
Jones, J. M. et al. Tick-borne relapsing fever outbreak among a high school football team at an outdoor education camping trip, Arizona, 2014. Am. J. Trop. Med. Hyg. 95(3), 546–550. https://doi.org/10.4269/ajtmh.16-0054 (2016).
doi: 10.4269/ajtmh.16-0054 pubmed: 27430539 pmcid: 5014256
Kingry, L. C. et al. Chromosome and linear plasmid sequences of a 2015 human isolate of the tick-borne relapsing fever spirochete, Borrelia turicatae. Genome Announc. 4(4), e00655-e716. https://doi.org/10.1128/genomeA.00655-16 (2016).
doi: 10.1128/genomeA.00655-16 pubmed: 27417836 pmcid: 4945796
Christensen, A. M. et al. Diagnosis and management of Borrelia turicatae infection in febrile soldier, Texas, USA. Emerg. Infect. Dis. 23(5), 883–884. https://doi.org/10.3201/eid2305.162069 (2017).
doi: 10.3201/eid2305.162069 pubmed: 28418310 pmcid: 5403040
Pritt, B. S. et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States. Int. J. Syst. Evol. Microbiol. 66(11), 4878–4880. https://doi.org/10.1099/ijsem.0.001445 (2016).
doi: 10.1099/ijsem.0.001445 pubmed: 27558626
Salkeld, D. J., Nieto, N. C., Bonilla, D. L., Yoshimizu, M. H. & Padgett, K. A. Borrelia miyamotoi infections in small mammals, California, USA. Emerg. Infect. Dis. 24(12), 2356–2359. https://doi.org/10.3201/eid2412.171632 (2018).
doi: 10.3201/eid2412.171632 pubmed: 30457525 pmcid: 6256383
Wagemakers, A., Oei, A., Fikrig, M. M., Miellet, W. R. & Hovius, J. W. The relapsing fever spirochete Borrelia miyamotoi is cultivable in a modified Kelly-Pettenkofer medium, and is resistant to human complement. Parasit. Vectors 7, 418. https://doi.org/10.1186/1756-3305-7-418 (2014).
doi: 10.1186/1756-3305-7-418 pubmed: 25189195 pmcid: 4261524
Munderloh, U. G., Liu, Y., Wang, M., Chen, C. & Kurtti, T. J. Establishment, maintenance and description of cell lines from the tick Ixodes scapularis. J. Parasitol. 80(4), 533–543. https://doi.org/10.2307/3283188 (1994).
doi: 10.2307/3283188 pubmed: 8064520
Munderloh, U. G. et al. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J. Clin. Microbiol. 37(8), 2518–2524 (1999).
doi: 10.1128/JCM.37.8.2518-2524.1999
Varela, A. S. et al. First culture isolation of Borrelia lonestari, putative agent of southern tick-associated rash illness. J. Clin. Microbiol. 42(3), 1163–1169. https://doi.org/10.1128/JCM.42.3.1163-1169.2004 (2004).
doi: 10.1128/JCM.42.3.1163-1169.2004 pubmed: 15004069 pmcid: 356874
Ullmann, A. J., Gabitzsch, E. S., Schulze, T. T., Zeidner, N. S. & Piesman, J. Three multiplex assays for detection of Borrelia burgdorferi sensu lato and Borrelia miyamotoi sensu lato in field-collected Ixodes nymphs in North America. J. Med. Entomol. 42(6), 1057–1062. https://doi.org/10.1093/jmedent/42.6.1057 (2005).
doi: 10.1093/jmedent/42.6.1057 pubmed: 16465748
Ivacic, L., Reed, K. D., Mitchell, P. D. & Ghebranious, N. A LightCycler TaqMan assay for detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn. Microbiol. Infect. Dis. 57(2), 137–143. https://doi.org/10.1016/j.diagmicrobio.2006.08.005 (2007).
doi: 10.1016/j.diagmicrobio.2006.08.005 pubmed: 16989975
Bissett, J. D. et al. Detection of tickborne relapsing fever spirochete, Austin, Texas, USA. Emerg. Infect. Dis. 24(11), 2003–2009. https://doi.org/10.3201/eid2411.172033 (2018).
doi: 10.3201/eid2411.172033 pubmed: 30160650 pmcid: 6199987

Auteurs

Adam J Replogle (AJ)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

Christopher Sexton (C)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

John Young (J)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

Luke C Kingry (LC)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

Martin E Schriefer (ME)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

Marc Dolan (M)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.

Tammi L Johnson (TL)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA.
Texas A&M AgriLife Research, Uvalde, TX, 78801, USA.

Neeta P Connally (NP)

Department of Biological and Environmental Sciences, Western Connecticut State University, Danbury, CT, 06810, USA.

Kerry A Padgett (KA)

California Department of Public Health, Infectious Diseases Branch/Vector-Borne Disease Section, Marina Bay Parkway, Richmond, CA, 94804, USA.

Jeannine M Petersen (JM)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, 80521, USA. nzp0@cdc.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH